logo
[breadcrumb_custom]

Tag: CLSD Stock

OPEN Stock
Industry

CLSD Stock: Exploring Clearside Biomedical Inc’s Growth

Clearside Biomedical Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $2.12 on 03/12/24, and the lowest price during the same period was recorded at $0.65 on 10/26/23. 52-week price history of CLSD Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Clearside Biomedical Inc’s current trading price is -26.42% away from its 52-week high, while its distance from the 52-week low is 139.96%. The stock’s price range for this period has remained between $0.65

News

CLSD’s 2023 Market Dance: Up 72.65% – Time to Invest?

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 72.65% this year. Over the last six months, there has been a weaker performance of 134.91%. The price of CLSD fallen by 46.38% during the last 30 days period. For the last 5-days stocks have improved 45.32%. The market performance of Clearside Biomedical Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $1.87 on 03/11/24, with the lowest value for the same timeframe being

Industry

Clearside Biomedical Inc (CLSD) Stock: From Low to High in 52 Weeks

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Clearside Biomedical Inc’s current trading price is -1.95% away from its 52-week high, while its distance from the 52-week low is 132.27%. The stock’s price range for this time frame has been between $0.65 and $1.54. The trading volume of the company’s shares in the Healthcare reached around 1.67 million for the day, which was evidently higher than the average daily volume of 0.19 million over the last three months. In terms of market performance, Clearside Biomedical Inc had